🇺🇸 FDA
Pipeline program

ssCART-19

ssCART-19-II-1

Phase 2 mab active

Quick answer

ssCART-19 for Relapsed or Refractory Acute Lymphoblastic Leukemia is a Phase 2 program (mab) at The First People's Hospital of Lianyungang with 1 ClinicalTrials.gov record(s).

Program details

Company
The First People's Hospital of Lianyungang
Indication
Relapsed or Refractory Acute Lymphoblastic Leukemia
Phase
Phase 2
Modality
mab
Status
active

Clinical trials